H.Res. 35: Expressing the sense of the House of Representatives that Congress should provide increased Federal funding for continued type 1 diabetes research

H.Res. 35

Expressing the sense of the House of Representatives that Congress should provide increased Federal funding for continued type 1 diabetes research

Sponsor
Rep. Gene Green

Date
December 8, 2009 (111th Congress, 1st Session)

Staff Contact
Sarah Makin

Floor Situation

H.Res. 35 is expected to be considered on the floor of the House on Tuesday, December 8, 2009, under a motion to suspend the rules, requiring a two-thirds vote for passage. The legislation was introduced by Rep. Gene Green (D-TX) on January 8, 2009.

Bill Summary

H.Res. 35 would resolve that federal funding for diabetes research should be increased to meet the National Institutes of Health's goals so that a cure for type 1 diabetes can be found. According to the resolution's findings, strong public-private partnership to fund type 1 diabetes exists between the federal government and the Juvenile Diabetes Research Foundation International, a foundation which has awarded more than $1 billion for diabetes research since its founding and in fiscal year 2008 provided more than $156,000,000 for diabetes research in 20 countries.

Background

Some Members may be concerned that this resolution encourages a "strong public-private partnership" between the federal government and the Juvenile Diabetes Research Foundation International (JRDF), an organization that explicitly supports human embryonic stem cell research, human cloning, and the expansion of federal government policies to support such research. Many Americans find the funding of this research with federal dollars to be unconscionable. To see more on the positions of the JRDF, see their website.

Members might wish to highlight the many advancements made in the field of adult stem cell technology, research that currently holds more near-term clinic benefit to individuals with wide ranges of diseases and is ethically noncontroversial.